Lotus Pharmaceutical Co.

Alvogen Korea, a subsidiary of the Lotus Group, is a global pharmaceutical company specializing in various therapeutic areas, ranging from obesity treatments to central nervous system disorders, kidney diseases, and cardiovascular medications, as well as general pharmaceutical products. Acknowledged as a market leader in the field of weight loss treatments, particularly appetite suppressants, Alvogen Korea strives to be at the forefront of the pharmaceutical industry by leveraging its concentrated expertise and advanced technologies in diverse therapeutic areas. With a mission to contribute to human health and improve patients' quality of life, Alvogen Korea adheres to global standards, maintains transparent management, and leads the market with better quality and standards in supplying standard pharmaceuticals.

Moreover, Alvogen Korea focuses on enhancing customer value through a wide range of information channels, from primary to tertiary healthcare facilities, and ensures the highest level of quality control in the production and supply of medications. Committed to making a difference, Alvogen Korea engages in various activities to create a warm and caring society